Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Post-Icu
AddedFeb 16, 2024
UpdatedJun 18, 2026
Post-Icu

Post-Icu

NY-based medical organization, Post-ICU, offers a digital diary for post-ICU patient support.

HQ
Nyack, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded in Nyack, New York, Post-ICU is a medical organization dedicated to supporting patients and their families after intensive care unit (ICU) experiences. The company's core mission is to provide clarity and emotional support through its primary product, a digital diary. This tool helps users understand the events that transpired during their ICU stay, fostering better mental health and recovery. Post-ICU focuses on aiding professional caregivers, hospitals, and patients' families, ensuring a comprehensive approach to post-ICU care.

Post-ICU has partnered with various healthcare professionals and institutions to enhance its offerings. The digital diary has received positive feedback for its role in helping ICU survivors process their experiences and recognize the quality of care they received. Through its innovative approach, Post-ICU has made a significant impact on patient recovery and mental well-being, establishing itself as a valuable resource in the healthcare community.

Post-Icu - Similar Companies

ICU Metrix logo

ICU Metrix

MedAux logo

MedAux

Nicolette logo

Nicolette

nicolette.com

Post Acute Analytics logo

Post Acute Analytics

paanalytics.com

eCareDiary logo

eCareDiary

RecoveryLink logo

RecoveryLink

MamaMend logo

MamaMend

VivorCare logo

VivorCare

vivorcare.com

Retrieve Medical logo

Retrieve Medical

Niveus Medical logo

Niveus Medical

niveusmedical.com

Caregivers Insight logo

Caregivers Insight

Medcorder logo

Medcorder

medcorder.com

Sentur logo

Sentur

sentur.health

NeuroPath logo

NeuroPath

neuropath.life

Patient Sortal logo

Patient Sortal

patientsortal.com

Post-Icu - Quick Facts

Who are Post-Icu's competitors?

Companies similar to Post-Icu include ICU Metrix, MedAux, Nicolette and Post Acute Analytics.

When was Post-Icu founded?

Post-Icu was founded in 2019.

Where is Post-Icu's headquarters located?

Post-Icu's headquarters is located in Nyack, NY, US.

When was Post-Icu's last funding round?

Post-Icu's most recent funding round was for $1M (USD) in July 2023.

How much has Post-Icu raised to-date?

As of Jul 28, 2023, Post-Icu has raised a total of $1M (USD).

How many employees does Post-Icu have?

Post-Icu has 30 employees as of Feb 4, 2024.

Post-Icu - Classification

Technology
  • Data
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Medical
  • Support
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals